BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Isogenica Limited Partners With CTC Laboratory Systems to Secure Business Development and Customer Support Operations in Japan


5/22/2012 10:12:59 AM

Cambridge, UK 22 May 2012: Isogenica today announces that it is appointing CTC Laboratory Systems Corporation (CTCLS) of Tokyo, Japan to represent the business in Japan. CTCLS are a leading force in the pharmaceutical research market in Japan and their skilled and knowledgeable employees ensure that Isogenica’s innovative technology for antibody, protein and peptide design will find a new customer base in Japan.

Dr Kevin Matthews, CEO, Isogenica commented: “The appointment of CTCLS is an important milestone for Isogenica and ensures that we can support our key customers in all the major world markets. We understand that direct personal contact, taking account of cultural and language differences, is fundamental to developing strong customer relationships. I am confident that CTCLS is the best organization to represent us and look forward to working with them to introduce Isogenica to the Japanese market as a whole as well as following-up on specific customer opportunities”.

Contact:

Kevin Matthews, CEO Isogenica - T: +44 (0)1799 533682 - E: kevin.matthews@isogenica.com

Rowan Gardner, Chairman, Biolauncher – T: +44 (0)1799 531635 – E: rowan@biolauncher.com

Rob Scoffin, CEO, Cresset BMD Ltd. – T: +44 (0)1707 356 120 – E: rob@cresset-group.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES